The latest closing stock price for Cidara Therapeutics as of September 18, 2024 is 11.62.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-964 today, roughly -1 times their original investment - a -30.82% compound annual growth rate over 9 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 24.40, which is 110% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.00, which is 13.9% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 14.25.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-964 today, roughly -1 times their original investment - a -30.82% compound annual growth rate over 9 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 24.40, which is 110% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.00, which is 13.9% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 14.25.